Get started
The Oncology Institute, Inc.The Oncology Institute, Inc.The Oncology Institute, Inc.

The Oncology Institute, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

TOI chart


Full chart

TOI upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪19.63 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.7915 USD
Net income (FY)
‪−67.88 M‬ USD
Revenue (FY)
‪324.24 M‬ USD
Shares float
‪36.77 M‬
Beta (1Y)
−0.04

Employees


Employees (FY)
800
Change (1Y)
+50 +6.67%
Revenue / Employee (1Y)
‪405.30 K‬ USD
Net income / Employee (1Y)
‪−84.85 K‬ USD

About The Oncology Institute, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Daniel Virnich
Website
theoncologyinstitute.com
Headquarters
Cerritos
Founded
2007
FIGI
BBG00S5H21H2
The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

TOI news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where TOI is featured.

See all sparks 

Frequently Asked Questions


The current price of TOI is 0.2600 USD — it has decreased by −4.66% in the past 24 hours. Watch The Oncology Institute, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange The Oncology Institute, Inc. stocks are traded under the ticker TOI.
TOI stock has fallen by −13.51% compared to the previous week, the month change is a −19.75% fall, over the last year The Oncology Institute, Inc. has showed a −86.60% decrease.
TOI reached its all-time high on Dec 27, 2021 with the price of 12.6600 USD, and its all-time low was 0.2731 USD and was reached on Sep 4, 2024. View more price dynamics on TOI chart.
See other stocks reaching their highest and lowest prices.
TOI stock is 11.55% volatile and has beta coefficient of −0.04. Track The Oncology Institute, Inc. stock price on the chart and check out the list of the most volatile stocks — is The Oncology Institute, Inc. there?
Today The Oncology Institute, Inc. has the market capitalization of ‪19.63 M‬, it has decreased by −3.96% over the last week.
Yes, you can track The Oncology Institute, Inc. financials in yearly and quarterly reports right on TradingView.
The Oncology Institute, Inc. is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
TOI earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.09 USD resulting in a −88.89% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about The Oncology Institute, Inc. earnings.
The Oncology Institute, Inc. revenue for the last quarter amounts to ‪98.60 M‬ USD, despite the estimated figure of ‪103.31 M‬ USD. In the next quarter, revenue is expected to reach ‪107.54 M‬ USD.
TOI net income for the last quarter is ‪−12.68 M‬ USD, while the quarter before that showed ‪−16.27 M‬ USD of net income which accounts for 22.08% change. Track more The Oncology Institute, Inc. financial stats to get the full picture.
No, TOI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 800.00 employees. See our rating of the largest employees — is The Oncology Institute, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. The Oncology Institute, Inc. EBITDA is ‪−57.22 M‬ USD, and current EBITDA margin is −16.70%. See more stats in The Oncology Institute, Inc. financial statements.
Like other stocks, TOI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade The Oncology Institute, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So The Oncology Institute, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating The Oncology Institute, Inc. stock shows the sell signal. See more of The Oncology Institute, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.